| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| WhiteOak Capital Pharma and Healthcare Fund (G) Direct |
| [Equity: Sectoral] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
2.73 |
| Equity |
93.48 |
| Treasury Bill |
2.86 |
| Trep |
0.93 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
36.57% |
| Top 10 Holdings |
54.47% |
| Top 25 Holdings |
84.46% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
65.6 |
| Healthcare |
23.3 |
| Cash |
3.66 |
| Chemicals |
3.0 |
| SOV |
2.86 |
| Consumer Durables |
1.58 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
6.25 |
| PE Ratio |
40.86 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| Sun Pharmaceutical Industries Limited |
12.35 |
| J B Chemicals and Pharma Ltd |
8.90 |
| Lupin Limited |
5.77 |
| DIVI LABORATORIES LTD |
5.31 |
| Apollo Hospitals Enterprise Limited |
4.24 |
| Laurus Labs Limited |
3.93 |
| Fortis Health Care Ltd |
3.85 |
| Max Healthcare Institute Limited |
3.79 |
| Glenmark Pharmaceuticals Limited |
3.17 |
| Krishna Inst of Medical Sciences Ltd. |
3.16 |
| Aurobindo Pharma Limited |
3.02 |
| Sai Life Sciences Limited |
2.77 |
| Net Receivables / (Payables) |
2.73 |
| ACUTAAS CHEMICALS LIMITED |
2.61 |
| Corona Remedies Limited |
2.27 |
| IPCA Laboratories Limited |
2.17 |
| Ajanta Pharma Limited |
2.11 |
| Emcure Pharmaceuticals Limited |
1.89 |
| Narayana Hrudalaya Ltd |
1.72 |
| Shaily Engineering Plastics Limited |
1.58 |
| Thyrocare Technologies Limited |
1.56 |
| Neuland Laboratories Limited |
1.42 |
| NAVIN FLUORINE INTERNATIONAL L |
1.41 |
| Aether Industries Limited |
1.38 |
| Pfizer Limited |
1.35 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|
